Wednesday, March 29, 2023
This activity is intended for ophthalmologists, cardiologists, hospital medicine clinicians, internists, nurses, and other members of the healthcare team who care for patients with eye stroke from central retinal artery occlusion (CRAO).
The goal of this activity is to describe the proportion of patients in whom atrial fibrillation (AF) is detected by extended cardiac monitoring after CRAO, according to a retrospective, observational cohort study using data from the Optum deidentified electronic health record (EHR) of 30.8 million people cross-referenced with the Medtronic CareLink database of 2.7 million people with cardiac monitoring devices.
Upon completion of this activity, participants will:
As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit for learning and change.
Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Awarded 0.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0 contact hours are in the area of pharmacology.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / ABIM MOC / CE Released: 7/30/2021
Valid for credit through: 7/30/2022
processing....
Central retinal artery occlusion (CRAO) is a rare form of ischemic stroke that causes sudden, irreversible blindness. Recent evidence suggests a common mechanism between CRAO and ischemic stroke and a reciprocal relationship between atrial fibrillation (AF) and CRAO.
Extended cardiac monitoring for the detection of AF should be considered in patients who have a stroke caused by CRAO, a new study suggests.
The study showed a high rate of device-detected AF in patients with central retinal artery occlusion, which was comparable to the rate in patients with cerebral ischemic stroke and higher than in matched control participants.
The study was published online June 7 in the journal Stroke.
"Central retinal artery occlusion -- also known as an eye stroke -- causes sudden, irreversible blindness in one eye and is a form of acute ischemic stroke," lead author Brian Mac Grory, MB BCh, told Medscape Medical News.
A recent cohort study found that 10% of patients with acute central retinal artery occlusion without a clear cause had AF on a 30-day cardiac event monitor, but the yield of extended cardiac monitoring in the diagnosis of new AF after an eye stroke is unknown, Mac Grory, a vascular neurologist at Duke University School of Medicine, Durham, North Carolina, noted.
To look more closely at the relationship between eye stroke and AF, the researchers conducted the current retrospective observational study in which information from two databases were cross referenced.
These were the Medtronic CareLink registry, which contains records from 2.7 million patients with implantable cardiac monitoring devices (insertable cardiac monitors, cardiac resynchronization therapy devices, or implantable pacemaker/defibrillators); and the Optum administrative dataset comprising electronic health records of approximately 30.8 million patients from 62 health systems in the United States.
"We identified patients who were in both databases and who had had a cerebral stroke or an eye stroke and matched them with patients also in both databases who had not had any type of stroke," Mac Grory explained.
After reviewing 884,431 patient records in common between the two databases, the researchers identified 100 patients with an eye stroke, 6559 with ischemic stroke, and 1000 matched control participants.
Results showed that patients who had an eye stroke were significantly more likely to have AF than matched patients without an eye stroke.
The cumulative incidence of new AF at 2 years was 49.6% on patients with an eye stroke. Patients with eye stroke had a significantly higher rate of AF than matched control participants (HR = 1.64 [95% CI: 1.17, 2.31]) and a comparable rate to patients with cerebral ischemic stroke (HR = 1.01 [95% CI: 0.75, 1.36]).
Patients with eye stroke also had a higher incidence of new stroke compared with matched control participants (HR = 2.85).
The higher rate of AF in patients with central retinal artery occlusion compared with control participants argues for potential causal association between subclinical AF and this condition, the authors stated.
"Because of close matching between groups, it is unlikely that our findings would otherwise be explained solely by the higher risk of cardiac disease in these patients," they added.
The researchers suggest that AF should be considered in the differential etiology of central retinal artery occlusion, and long-term cardiac monitoring may be a reasonable option as part of the diagnostic workup in patients with eye stroke without known cause.
"Our study strengthens the link between eye stroke and AF. We can now cautiously say that if a patient has had an eye stroke it is reasonable to check for AF if no other reason for the stroke has been identified," Mac Grory said.
"As this was a retrospective study, it is not enough to change practice," he added. "More research is needed to be able to make stronger recommendations for monitoring, but I think this study poses an interesting question about monitoring in patients with these eye strokes, and it would be a reasonable thing to do."
Mac Grory noted that eye strokes are quite rare: accounting for < 1% of all strokes. The condition is not often recognized as being a stroke, as it does not cause the traditional stroke symptoms of weakness and difficulty with speech and cognition but rather presents as sudden painless vision loss in one eye.
"Patients are rarely recognized to be having a medical emergency and are often referred to an eye clinic and a diagnosis of central retinal artery occlusion is often very delayed," Mac Grory commented, "[b]ut this condition needs more recognition. It should be viewed as a canary in the coal mine -- that there is something wrong -- as it can often be followed by a disabling brain stroke.
"If patients present with sudden vision loss in one eye, then an eye stroke should be considered. This can be treated with thrombolysis if patients get to the hospital within the 4.5-hour time window," he added.
This study did not receive any commercial funding. Mac Grory has disclosed no relevant financial relationships.
Stroke. Published online June 7, 2021.[1]
